• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Diversey Holdings Ltd.

    2/14/22 4:17:18 PM ET
    $DSEY
    Specialty Chemicals
    Consumer Discretionary
    Get the next $DSEY alert in real time by email
    SC 13G 1 d274437dsc13g.htm SC 13G SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

     

    SCHEDULE 13G

    (Rule 13d-102)

    Information to be Included in Statements Filed Pursuant

    to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

    Pursuant to § 240.13d-2

    Under the Securities Exchange Act of 1934

    (Amendment No.     )

     

     

    Diversey Holdings, Ltd.

    (Name of Issuer)

    Ordinary Shares, $0.0001

    par value per share

    (Title of Class of Securities)

    G28923103

    (CUSIP Number)

    December 31, 2021

    (Date of Event Which Requires Filing of This Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (“Act”), or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. G28923103   13G   Page 2 of 6

     

      1    

      Names of reporting persons

     

      BCPE Diamond Investor, LP

      2  

      Check the appropriate box if a member of a group

     

      (a)  ☐        (b)  ☐

     

      3  

      SEC use only

     

      4  

      Citizenship or place of organization

     

      Delaware

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with:

       5    

      Sole voting power

     

      0 Ordinary Shares

       6  

      Shared voting power

     

      236,561,159 Ordinary Shares

       7  

      Sole dispositive power

     

      0 Ordinary Shares

       8  

      Shared dispositive power

     

      236,561,159 Ordinary Shares

      9    

      Aggregate amount beneficially owned by each reporting person

     

      236,561,159 Ordinary Shares

    10  

      Check if the aggregate amount in Row (9) excludes certain shares

     

      ☐

    11  

      Percent of class represented by amount in Row (9)

     

      74.5%

    12  

      Type of reporting person

     

      PN


    CUSIP No. G28923103   13G   Page 3 of 6

     

    Item 1(a). Name of Issuer

    The name of the issuer to which this filing on Schedule 13G relates is Diversey Holdings, Ltd. (the “Issuer”).

    Item 1(b). Address of Issuer’s Principal Executive Offices

    The principal executive offices of the Issuer are located at 1300 Altura Road, Suite 125, Fort Mill, South Carolina 29708.

    Item 2(a). Name of Person Filing

    This Schedule 13G is being filed by BCPE Diamond Investor, LP, a Delaware limited partnership (the “Reporting Person”).

    Bain Capital Fund XI, L.P., a Cayman Islands exempted limited partnership (“Fund XI”), is the sole member of BCPE Diamond GP, LLC, a Delaware limited liability company (“BCPE Diamond GP”), which is the general partner of the Reporting Person. Bain Capital Partners XI, L.P., a Cayman Islands exempted limited partnership (“Partners XI”), is the general partner of Fund XI. Bain Capital Investors, LLC, a Delaware limited liability company (“BCI” and collectively with the Reporting Person, BCPE Diamond GP, Fund XI and Partners XI, the “Bain Capital Entities”), is the general partner of Partners XI. As a result, BCI may be deemed to share voting and dispositive power with respect to the securities held by the Reporting Person. Voting and investment decisions with respect to securities held by the Bain Capital Entities are made by the managing directors of BCI.

    Item 2(b). Address of Principal Business Office or, if None, Residence

    The principal business address for each of the Bain Capital Entities is 200 Clarendon Street, Boston, Massachusetts 02116.

    Item 2(c). Citizenship

    Each of the Reporting Person, BCPE Diamond GP and BCI is organized under the laws of the State of Delaware. Each of Fund XI and Partners XI is organized under the laws of the Cayman Islands.

    Item 2(d). Title of Class of Securities

    The class of securities of the Issuer to which this Schedule 13G relates is Ordinary Shares, $0.0001 par value per share (“Ordinary Shares”).

    Item 2(e). CUSIP Number

    The CUSIP number of the Ordinary Shares is G28923103.

    Item 3. If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a

     

      (a)

    ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

     

      (b)

    ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

     

      (c)

    ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

     

      (d)

    ☐ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);


    CUSIP No. G28923103   13G   Page 4 of 6

     

      (e)

    ☐ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

     

      (f)

    ☐ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

      (g)

    ☐ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     

      (h)

    ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

      (i)

    ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

     

      (j)

    ☐ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

     

      (k)

    ☐ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

    If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution.

    Item 4. Ownership

    (a) Amount beneficially owned:

    As of the close of business on December 31, 2021, the Reporting Person held 236,561,159 Ordinary Shares, representing approximately 74.5% of the outstanding Ordinary Shares.

    The percentage of the outstanding Ordinary Shares held by the Reporting Person is based on 317,431,140 Ordinary Shares issued and outstanding, as reported by the Issuer in its prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, on November 12, 2021.

    (b) Percent of class:

    See Item 4(a) hereof.

    (c) Number of shares as to which the person has:

    (i) Sole power to vote or to direct the vote:

    0

    (ii) Shared power to vote or direct the vote:

    236,561,159

    (iii) Sole power to dispose or to direct the disposition of:

    0

    (iv) Shared power to dispose or to direct the disposition of:

    236,561,159

    Item 5. Ownership of Five Percent or Less of a Class

    Not applicable.

    Item 6. Ownership of More than Five Percent on Behalf of Another Person

    Not applicable.


    CUSIP No. G28923103   13G   Page 5 of 6

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

    Not applicable.

    Item 8. Identification and Classification of Members of the Group

    Not applicable.

    Item 9. Notice of Dissolution of Group

    Not applicable.

    Item 10. Certifications

    Not applicable.


    CUSIP No. G28923103   13G   Page 6 of 6

     

    SIGNATURES

    After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information in this statement is true, complete and correct.

     

    Dated: February 14, 2022     BCPE Diamond Investor, LP
        By:   BCPE Diamond GP, LLC,
          its general partner
        By:  

    /s/ Michael D. Ward

          Name:   Michael D. Ward
          Title:   Authorized Signatory
    Get the next $DSEY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DSEY

    DatePrice TargetRatingAnalyst
    2/22/2023$6.00Underperform
    BofA Securities
    12/15/2022$5.80Market Perform
    BMO Capital Markets
    10/5/2022Buy → Neutral
    Citigroup
    6/16/2022$12.00 → $10.00Buy → Hold
    Jefferies
    5/20/2022$11.00 → $12.00Outperform
    Credit Suisse
    3/25/2022$11.00 → $9.00Outperform → Sector Perform
    RBC Capital Mkts
    3/11/2022$19.00 → $15.00Overweight
    Morgan Stanley
    3/11/2022$14.00 → $11.00Outperform
    RBC Capital
    More analyst ratings

    $DSEY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • New Study from Diversey shows that contact time and disinfectant formulation has a significant impact on the efficacies of disinfectant towelettes on hard, non-porous surfaces

      UTRECHT, Netherlands, June 7, 2023 /PRNewswire/ -- Diversey Holdings, Ltd. (NASDAQ:DSEY), a leading provider of hygiene, infection prevention, and cleaning solutions has demonstrated in a recent study by Purdue University that disinfectant efficacy against Candida auris (C. auris) varied significantly with both product formula and contact time having a significant impact on disinfectant efficacy. The study suggests that healthcare facilities wanting the best hygiene outcomes should use disinfectants with an EPA approved label claim against C. auris and should ensure the surface is kept wet for the contact time listed on the label.

      6/7/23 4:00:00 AM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary
    • Diversey Reports First Quarter 2023 Results

      Reported sales +5.5% compared to prior year; +12.6% adjusted for constant currencyLoss before taxes of $44.3 million for the first quarter, representing loss before taxes margin of (6.4)% Adjusted EBITDA was $52.6 million, representing Adjusted EBITDA margin of 7.6% FORT MILL, S.C., May 04, 2023 (GLOBE NEWSWIRE) -- Diversey Holdings, Ltd. ("Diversey") (NASDAQ:DSEY) announces first quarter results. UnauditedFirst Quarter Ended March 31(millions) 2023  2022 % ChangeNet sales$696.0 $660.0 5.5%Loss before taxes (44.3) (37.2)(19.1)%% Margin(6.4)%(5.6)%(80) bpsNet loss (53.6) (39.1)(37.1)%Adjusted net income (loss)(1) 1.5  3.7 (59.5)%    Adjusted EBITDA(1) 52.6  60.3 (12.8)%% Margin(1) 7.6% 9.

      5/4/23 7:59:00 AM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary
    • New study from Diversey shows that different choices of manual floor mopping materials provide different hygiene outcomes

      UTRECHT, Netherlands, April 24, 2023 /PRNewswire/ -- Diversey Europe Operations B.V. (NASDAQ:DSEY), a leading provider of hygiene, infection prevention, and cleaning solutions recently published a study to demonstrate the importance of floor disinfection in reducing risks associated with floor hygiene. The Authors of the study suggest that commercial facilities wanting the best hygiene outcomes and using manual floor mopping as part of their facility hygiene program should consider the use of biocidal floor products with either launderable or disposable flat mops and avoid the use of cotton string mops and neutral cleaners.

      4/24/23 4:00:00 AM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary

    $DSEY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BofA Securities resumed coverage on Diversey Holdings with a new price target

      BofA Securities resumed coverage of Diversey Holdings with a rating of Underperform and set a new price target of $6.00

      2/22/23 6:12:34 AM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary
    • BMO Capital Markets initiated coverage on Diversey Holdings with a new price target

      BMO Capital Markets initiated coverage of Diversey Holdings with a rating of Market Perform and set a new price target of $5.80

      12/15/22 7:41:26 AM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary
    • Diversey Holdings downgraded by Citigroup

      Citigroup downgraded Diversey Holdings from Buy to Neutral

      10/5/22 9:04:01 AM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary

    $DSEY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Hanau Kenneth

      4 - Diversey Holdings, Ltd. (0001831617) (Issuer)

      7/6/23 4:16:06 PM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form 4 filed by Bain Capital Investors Llc

      4 - Diversey Holdings, Ltd. (0001831617) (Issuer)

      7/6/23 4:12:03 PM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form 4 filed by Levine Susan Bruno

      4 - Diversey Holdings, Ltd. (0001831617) (Issuer)

      7/6/23 4:09:56 PM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary

    $DSEY
    SEC Filings

    See more
    • SEC Form 15-12G filed by Diversey Holdings Ltd.

      15-12G - Diversey Holdings, Ltd. (0001831617) (Filer)

      7/17/23 4:06:15 PM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form SC 13E3/A filed by Diversey Holdings Ltd. (Amendment)

      SC 13E3/A - Diversey Holdings, Ltd. (0001831617) (Subject)

      7/5/23 5:13:11 PM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form S-8 POS filed by Diversey Holdings Ltd.

      S-8 POS - Diversey Holdings, Ltd. (0001831617) (Filer)

      7/5/23 4:23:44 PM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary

    $DSEY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Diversey Holdings Ltd.

      SC 13G - Diversey Holdings, Ltd. (0001831617) (Subject)

      2/14/22 4:17:18 PM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary

    $DSEY
    Leadership Updates

    Live Leadership Updates

    See more
    • Diversey Announces Appointment of Eric Foss as Chairman of the Board

      FORT MILL, S.C., March 17, 2022 (GLOBE NEWSWIRE) -- Diversey Holdings, Ltd. (NASDAQ:DSEY), a leading provider of hygiene, infection prevention and cleaning solutions, today announced that its Board of Directors has appointed Eric Foss as Chairman of the Board effective March 17. Foss succeeds Selim Bassoul who will remain a Director. Mr. Foss has been a Director since Diversey's IPO in March 2021. "Eric is a highly successful leader, with a proven track record of driving growth, creating sustainable shareholder value, building high performance teams and creating a purpose driven legacy for global at scale companies," said Phil Wieland, Diversey's CEO. "I look forward to continuing to w

      3/17/22 8:30:00 AM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary
    • Diversey Appoints Katherine S. Zanotti to its Board of Directors

      FORT MILL, S.C., March 01, 2022 (GLOBE NEWSWIRE) -- Diversey Holdings, Ltd. (NASDAQ:DSEY), a leading provider of hygiene, infection prevention and cleaning solutions, has appointed Katherine S. Zanotti to the company's board of directors, effective March 1, 2022. This appointment will bring the total number of directors to eleven. "We are delighted to welcome Katherine (‘Kay') to our board. Kay's long history of leadership coupled with her extensive experience in sales and marketing within the foodservice and health care sectors makes her a great addition and helps position Diversey for continued growth and success," said Phil Wieland, CEO of Diversey.     Katherine S. Zanotti served as

      3/1/22 8:30:00 AM ET
      $CUTR
      $DSEY
      $EXAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
      Specialty Chemicals
      Consumer Discretionary
    • Diversey Appoints Rod Hochman, M.D. to its Board of Directors

      FORT MILL, S.C., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Diversey Holdings, Ltd. (NASDAQ:DSEY), a leading provider of hygiene, infection prevention and cleaning solutions, has appointed Rod Hochman, M.D. to the company's board of directors, effective September 1, 2021. This appointment will bring the total number of directors to ten. "We are extremely pleased to welcome Rod to our board," said Phil Wieland, CEO of Diversey. "His extensive background in the healthcare sector makes Rod a great addition and helps position Diversey for continued growth and success in that area."     Rod Hochman, M.D. has been the President and Chief Executive Officer of Providence, a not-for-profit health system s

      9/1/21 8:18:44 AM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary

    $DSEY
    Financials

    Live finance-specific insights

    See more
    • Diversey Reports First Quarter 2023 Results

      Reported sales +5.5% compared to prior year; +12.6% adjusted for constant currencyLoss before taxes of $44.3 million for the first quarter, representing loss before taxes margin of (6.4)% Adjusted EBITDA was $52.6 million, representing Adjusted EBITDA margin of 7.6% FORT MILL, S.C., May 04, 2023 (GLOBE NEWSWIRE) -- Diversey Holdings, Ltd. ("Diversey") (NASDAQ:DSEY) announces first quarter results. UnauditedFirst Quarter Ended March 31(millions) 2023  2022 % ChangeNet sales$696.0 $660.0 5.5%Loss before taxes (44.3) (37.2)(19.1)%% Margin(6.4)%(5.6)%(80) bpsNet loss (53.6) (39.1)(37.1)%Adjusted net income (loss)(1) 1.5  3.7 (59.5)%    Adjusted EBITDA(1) 52.6  60.3 (12.8)%% Margin(1) 7.6% 9.

      5/4/23 7:59:00 AM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary
    • Diversey Reports Fourth Quarter and Full Year 2022 Results

      Reported sales +4.3% in the fourth quarter compared to prior year and full year 2022 reported sales +5.6%Net loss of $59.5 million for the fourth quarter and $169.3 million for full year 2022 Fourth quarter Adjusted EBITDA was $93.4 million, representing Adjusted EBITDA margin of 13.3%Full year Adjusted EBITDA was $330.1 million, representing Adjusted EBITDA margin of 11.9% FORT MILL, S.C., March 17, 2023 (GLOBE NEWSWIRE) -- Diversey Holdings, Ltd. ("Diversey") (NASDAQ:DSEY) announced fourth quarter and full year results.  Year Ended December 31(millions) 2022  2021 % ChangeNet sales$2,765.9 $2,618.9 5.6%Loss before taxes (185.5) (149.5)(24.1)%Net loss (169.3) (174.8)3.1%Adjusted net inc

      3/17/23 4:29:28 PM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary
    • Diversey to be Acquired by Solenis for $4.6 Billion

      Diversey Public Shareholders to Receive $8.40 Per Share in Cash in "Go Private" Transaction Combined company will allow for expanded markets and additional sustainable solutions Solenis ("Solenis") and Diversey Holdings, Ltd. ("Diversey" or the "Company") (NASDAQ:DSEY) today announced they have entered into a definitive merger agreement under which Solenis will acquire Diversey in an all-cash transaction valued at an enterprise value of approximately $4.6 billion. Upon completion of the merger, Diversey will become a private company. Under the terms of the agreement, Diversey shareholders (other than shareholders affiliated with Bain Capital Private Equity ("Bain Capital")) will receive

      3/8/23 6:59:00 AM ET
      $DSEY
      Specialty Chemicals
      Consumer Discretionary